Copyright Reports & Markets. All rights reserved.

Global Glycobiology (Diagnostics and Therapeutics) Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Glycobiology (Diagnostics and Therapeutics) Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Diagnostics
      • 1.4.3 Therapeutics
    • 1.5 Market by Application
      • 1.5.1 Global Glycobiology (Diagnostics and Therapeutics) Market Share by Application (2014-2025)
      • 1.5.2 Clinic
      • 1.5.3 Hospital
      • 1.5.4 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Glycobiology (Diagnostics and Therapeutics) Market Size
    • 2.2 Glycobiology (Diagnostics and Therapeutics) Growth Trends by Regions
      • 2.2.1 Glycobiology (Diagnostics and Therapeutics) Market Size by Regions (2014-2025)
      • 2.2.2 Glycobiology (Diagnostics and Therapeutics) Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Glycobiology (Diagnostics and Therapeutics) Market Size by Manufacturers
      • 3.1.1 Global Glycobiology (Diagnostics and Therapeutics) Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Glycobiology (Diagnostics and Therapeutics) Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Glycobiology (Diagnostics and Therapeutics) Market Concentration Ratio (CR5 and HHI)
    • 3.2 Glycobiology (Diagnostics and Therapeutics) Key Players Head office and Area Served
    • 3.3 Key Players Glycobiology (Diagnostics and Therapeutics) Product/Solution/Service
    • 3.4 Date of Enter into Glycobiology (Diagnostics and Therapeutics) Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Glycobiology (Diagnostics and Therapeutics) Market Size by Type (2014-2019)
    • 4.2 Global Glycobiology (Diagnostics and Therapeutics) Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Glycobiology (Diagnostics and Therapeutics) Market Size (2014-2019)
    • 5.2 Glycobiology (Diagnostics and Therapeutics) Key Players in United States
    • 5.3 United States Glycobiology (Diagnostics and Therapeutics) Market Size by Type
    • 5.4 United States Glycobiology (Diagnostics and Therapeutics) Market Size by Application

    6 Europe

    • 6.1 Europe Glycobiology (Diagnostics and Therapeutics) Market Size (2014-2019)
    • 6.2 Glycobiology (Diagnostics and Therapeutics) Key Players in Europe
    • 6.3 Europe Glycobiology (Diagnostics and Therapeutics) Market Size by Type
    • 6.4 Europe Glycobiology (Diagnostics and Therapeutics) Market Size by Application

    7 China

    • 7.1 China Glycobiology (Diagnostics and Therapeutics) Market Size (2014-2019)
    • 7.2 Glycobiology (Diagnostics and Therapeutics) Key Players in China
    • 7.3 China Glycobiology (Diagnostics and Therapeutics) Market Size by Type
    • 7.4 China Glycobiology (Diagnostics and Therapeutics) Market Size by Application

    8 Japan

    • 8.1 Japan Glycobiology (Diagnostics and Therapeutics) Market Size (2014-2019)
    • 8.2 Glycobiology (Diagnostics and Therapeutics) Key Players in Japan
    • 8.3 Japan Glycobiology (Diagnostics and Therapeutics) Market Size by Type
    • 8.4 Japan Glycobiology (Diagnostics and Therapeutics) Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Glycobiology (Diagnostics and Therapeutics) Market Size (2014-2019)
    • 9.2 Glycobiology (Diagnostics and Therapeutics) Key Players in Southeast Asia
    • 9.3 Southeast Asia Glycobiology (Diagnostics and Therapeutics) Market Size by Type
    • 9.4 Southeast Asia Glycobiology (Diagnostics and Therapeutics) Market Size by Application

    10 India

    • 10.1 India Glycobiology (Diagnostics and Therapeutics) Market Size (2014-2019)
    • 10.2 Glycobiology (Diagnostics and Therapeutics) Key Players in India
    • 10.3 India Glycobiology (Diagnostics and Therapeutics) Market Size by Type
    • 10.4 India Glycobiology (Diagnostics and Therapeutics) Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Glycobiology (Diagnostics and Therapeutics) Market Size (2014-2019)
    • 11.2 Glycobiology (Diagnostics and Therapeutics) Key Players in Central & South America
    • 11.3 Central & South America Glycobiology (Diagnostics and Therapeutics) Market Size by Type
    • 11.4 Central & South America Glycobiology (Diagnostics and Therapeutics) Market Size by Application

    12 International Players Profiles

    • 12.1 Biomarin Pharmaceutical Inc.
      • 12.1.1 Biomarin Pharmaceutical Inc. Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Glycobiology (Diagnostics and Therapeutics) Introduction
      • 12.1.4 Biomarin Pharmaceutical Inc. Revenue in Glycobiology (Diagnostics and Therapeutics) Business (2014-2019)
      • 12.1.5 Biomarin Pharmaceutical Inc. Recent Development
    • 12.2 Glycomimetics
      • 12.2.1 Glycomimetics Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Glycobiology (Diagnostics and Therapeutics) Introduction
      • 12.2.4 Glycomimetics Revenue in Glycobiology (Diagnostics and Therapeutics) Business (2014-2019)
      • 12.2.5 Glycomimetics Recent Development
    • 12.3 Glycan Biosciences Llc
      • 12.3.1 Glycan Biosciences Llc Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Glycobiology (Diagnostics and Therapeutics) Introduction
      • 12.3.4 Glycan Biosciences Llc Revenue in Glycobiology (Diagnostics and Therapeutics) Business (2014-2019)
      • 12.3.5 Glycan Biosciences Llc Recent Development
    • 12.4 Glycosensors And Diagnostics Llc
      • 12.4.1 Glycosensors And Diagnostics Llc Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Glycobiology (Diagnostics and Therapeutics) Introduction
      • 12.4.4 Glycosensors And Diagnostics Llc Revenue in Glycobiology (Diagnostics and Therapeutics) Business (2014-2019)
      • 12.4.5 Glycosensors And Diagnostics Llc Recent Development
    • 12.5 Glycotest Inc.
      • 12.5.1 Glycotest Inc. Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Glycobiology (Diagnostics and Therapeutics) Introduction
      • 12.5.4 Glycotest Inc. Revenue in Glycobiology (Diagnostics and Therapeutics) Business (2014-2019)
      • 12.5.5 Glycotest Inc. Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Glycobiology is the study of the structure, biosynthesis, and biology of saccharides that are widely distributed in nature. Glycobiology is the study of the structure, function and biology of carbohydrates, also called glycans. Glycans are present in every living organism. Glycobiology is a rapidly growing field in biology, with relevance to biomedicine, biotechnology and basic research.
      Glycans are diverse, complex molecules and their functions are determined by their unique structures. Effective enzymatic tools and analytical techniques are required to properly elucidate glycan structure, which can then be correlated to a specific function.
      Glycosylation defines the adhesive properties of proteins and cells. The immune system largely functions via glycan-protein interactions, which highlights the importance of glycans in physiology, pathogen recognition, cancer and autoimmune diseases.
      Glycan molecules modulate many other processes important for cell and tissue differentiation, metabolic and gene regulation, protein activity, protein clearance, transport and more.
      In 2018, the global Glycobiology (Diagnostics and Therapeutics) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Glycobiology (Diagnostics and Therapeutics) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Glycobiology (Diagnostics and Therapeutics) development in United States, Europe and China.

      The key players covered in this study
      Biomarin Pharmaceutical Inc.
      Glycomimetics
      Glycan Biosciences Llc
      Glycosensors And Diagnostics Llc
      Glycotest Inc.
      ...

      Market segment by Type, the product can be split into
      Diagnostics
      Therapeutics

      Market segment by Application, split into
      Clinic
      Hospital
      Other

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Glycobiology (Diagnostics and Therapeutics) status, future forecast, growth opportunity, key market and key players.
      To present the Glycobiology (Diagnostics and Therapeutics) development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Glycobiology (Diagnostics and Therapeutics) are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now